July 20, 2021
RFA-CA-21-038 - Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
RFA-CA-21-039 - Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
This Notice informs the applicant community that the National Cancer Institute (NCI) will hold a pre-application webinarfor Funding Opportunity Announcements (FOAs) RFA-CA-21-038 and RFA-CA-21-039, entitled "Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)" and “Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed),” respectively.
NCI staff members involved in these FOAs will provide orientation and technical assistance to potential applicants to the above-referenced FOAs by explaining the goals and objectives for the proposed FOAs and answer questions from webinar attendees.
Potential applicants are encouraged to submit questions when registered to the pre-application webinar or send questions to [email protected] by 12:00 PM ET on August 10th, 2021.
Webinar Information:
Date: August 16, 2021
Time: 1:00 - 2:00 PM (ET)
To join the Webinar, pre-registration is required through Webex.
To register for the August 16, 2021, webinar, please go to:
Pre-application Webinar for CAP-IT Program RFAs
Specific webinar details will be provided upon registration.
Participation in this webinar, although highly encouraged, is optional and is not required for the submission applications in response to RFA-CA-21-038 and RFA-CA-21-039, respectively.
The webinar will be recorded for those who are not able to participate in the live event. A document highlighting frequently asked questions and corresponding answers will be posted, along with the webinar recording, to the following website approximately 2-3 weeks after the webinar: at CAP-IT.
Shizuko Sei, M.D.
Division of Cancer Prevention
National Cancer Institute (NCI)
Telephone: 240-276-5005
Email: [email protected]